Vaccines News StoriesExcerpts of Key Vaccines News Stories in Major Media
Note: This comprehensive list of vaccines news stories is usually updated once a week. Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.
Pfizer is expected to seek federal permission to release its Covid-19 vaccine by the end of November. The vaccine, and likely most others, will require two doses to work, injections that must be given weeks apart. The shots will cause enervating flu-like side effects – including sore arms, muscle aches and fever – that could last days and temporarily sideline some people from work or school. And even if a vaccine proves 90 percent effective ... 1 in 10 recipients would still be vulnerable. That means, at least in the short term, as population-level immunity grows, people can't stop social distancing and throw away their masks. Left out so far ... has been a large-scale plan to communicate effectively about those issues in advance, said Saad Omer, director of the Yale Institute for Global Health. Such broad-based outreach will be necessary in a country where, as of mid-October, only half of Americans said they'd be willing to get a Covid-19 vaccine. "We are asking people to take a vaccine that is going to hurt," said Dr. William Schaffner, a professor of preventive medicine and health policy at Vanderbilt. "There are lots of sore arms and substantial numbers of people who feel crummy, with headaches and muscle pain, for a day or two." Persuading people who experience those symptoms to return in three to four weeks for a second dose – and a second round of flu-like symptoms – could be a tough sell, Schaffner said. A professor of internal medicine and epidemiology at University of Iowa [suggested] that essential workers should be granted three days of paid leave after they're vaccinated.
Important Note: Learn about the serious dangers of these mRNA vaccines through the vitally important information given by Christiane Northrup, MD, in the first five minutes of this revealing video. Dr. Northrup's work has been featured on NBC Nightly News, Good Morning America, Oprah, Dr. Oz, and more. And an informative article in the UK's Independent by another medical doctor states, "There are unique and unknown risks to messenger RNA vaccines, including the possibility that they ... could lead to inflammation and autoimmune conditions."
As of Sunday, a total [of] 1,231 people in South Korea reported side effects after getting the flu shot this year, according to health authorities. Last week, the Korean Medical Association "recommended to withhold vaccination for one week," but clarified it was not suggesting vaccinations be stopped. Of the 59 people who died after receiving the flu vaccine this year (up from 48 on Saturday), 46 of those deaths were believed to have no connection to the flu shot. An investigation into the 13 remaining fatalities has been launched, the Korea Disease Control and Prevention Agency (KDCA) revealed. More than 9.4 million people in South Korea have received the flu shot so far since this year's vaccination program began in September. The KDCA noted the latest number of deaths following the flu vaccination is not greater than previous years. Last year, 1,531 people aged 65 years and older died within seven days after receiving a flu shot, according to the KDCA. President Moon noted Monday: "This year, it is necessary to expand flu vaccinations not only to prevent the flu, but also to prevent simultaneous infection and spread of the flu and coronavirus."
Note: How much can we trust authorities who are clearly biased towards promoting vaccines? For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
Previous vaccines have taken a decade or more to develop, and more than half of the past 20 years have failed in clinical trials. However, four [COVID-19] vaccine candidates have entered the final phase of clinical trials prior to approval by the Food and Drug Administration. Operation Warp Speed ... organized government agencies and private companies with the goal of developing, manufacturing and distributing hundreds of millions of vaccine doses, with starting doses to be available by early 2021. At the head of the operation is Moncef Slaoui, a Moroccan-born Belgian-American scientist. Operation Warp Speed â€¦ has invested in six vaccine candidates (Moderna, Pfizer / BioNTech, Johnson & Johnson, AstraZeneca, Novavax, and Sanofi / GSK) with the hope that at least one ... will prove safe and effective in clinical trials. Four of the six vaccine candidates have already been shown to be safe and effective in the first two test phases, which test whether the vaccinations produce so-called neutralizing antibodies. Serious health problems regularly arise during vaccination attempts. "We know how to distribute vaccines to any location in the US," says Slaoui. "It happens every year for flu and shingles." Tracking systems need to be "incredibly precise" to ensure that patients are each given two doses of the same vaccine and to monitor them for adverse health effects. Operation Warp Speed â€¦ has selected medical distributor McKesson and cloud operators Google and Oracle to collect and track vaccine data.
Note: The above article is also available here. Don't miss this excellent article which raises many important questions about this operation. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.
The Trump administration has compared Operation Warp Speed's crash program to develop a COVID-19 vaccine to the Manhattan Project. And like the notoriously secretive government project to make the first atomic bomb, the details of Operation Warp Speed's work may take a long time to unravel. One reason is that Operation Warp Speed is issuing billions of dollars' worth of coronavirus vaccine contracts to companies through a nongovernment intermediary, bypassing the regulatory oversight and transparency of traditional federal contracting mechanisms, NPR has learned. Instead of entering into contracts directly with vaccine makers, more than $6 billion in Operation Warp Speed funding has been routed through a defense contract management firm called Advanced Technologies International, Inc. ATI then awarded contracts to companies working on COVID-19 vaccines. As a result, the contracts between the pharmaceutical companies and ATI may not be available through public records requests, and additional documents are exempt from public disclosure for five years. [Robin] Feldman, of UC Hastings, says the administration's comparison of Operation Warp Speed to the Manhattan Project is troubling. "I think that's completely the wrong image," she says. "The right analogy, I think, for Operation Warp Speed is the penicillin effort in World War II. We can do a lot of good together, but we have to make sure pharma companies aren't taking advantage of the crisis."
Note: Read an excellent article showing how most of these contracts are linked to the CIA and DHS and more. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and the coronavirus from reliable major media sources.
Whether the coronavirus vaccine developed by Moderna succeeds or not, executives at the small biotech company have already made tens of millions of dollars by cashing in their stock. An NPR examination of official company disclosures has revealed additional irregularities and potential warning signs. Since January, CEO StĂ©phane Bancel has sold roughly $40 million worth of Moderna stock; Chief Medical Officer Tal Zaks has sold around $60 million; and President Stephen Hoge has sold more than $10 million. The stock sales first came to widespread notice after Moderna announced positive early data from a vaccine trial in May. At that point, the company's share price jumped and official disclosures showed executives cashing in their shares for millions of dollars. Advocates have questioned whether it's appropriate for executives to privately profit before bringing the vaccine to market, especially when American taxpayers have committed roughly $2.5 billion to the company's vaccine development. Moderna says its executives pre-scheduled their stock sales long in advance. Those schedules - known as 10b5-1 plans - can act as a defense to charges of insider trading. But the plans have to be put in place when executives do not have confidential inside information. NPR has found multiple executives adopted or modified their plans just before key announcements about the company's vaccine. That has raised questions about whether they were aware of nonpublic information when they planned their stock trades.
Note: Explore a revealing NBC article titled "Secret, powerful panels will pick Covid-19 vaccine winners." For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma corruption from reliable major media sources.
AstraZeneca revealed details of its large coronavirus vaccine trials on Saturday, the third in a wave of rare disclosures by drug companies under pressure to be more transparent about how they are testing products that are the world's best hope for ending the pandemic. Polls are finding Americans increasingly wary of accepting a coronavirus vaccine. Experts have been particularly concerned about AstraZeneca's vaccine trials, which began in April in Britain, because of the company's refusal to provide details about serious neurological illnesses in two participants, both women, who received its experimental vaccine in Britain. Those cases spurred the company to halt its trials twice, the second time earlier this month. The studies have resumed in Britain, Brazil, India and South Africa, but are still on pause in the U.S. About 18,000 people worldwide have received AstraZeneca's vaccine so far. The company has released few details about the two cases of serious illness in its trial. The first participant received one dose of the vaccine before developing inflammation of the spinal cord, known as transverse myelitis. The condition can cause weakness in the arms and legs, paralysis, pain and bowel and bladder problems. The company said it had not confirmed a diagnosis in the second case, a participant who got sick after the second dose of the vaccine. A person familiar with the situation who spoke with The Times on the condition of anonymity said the participant's illness had been pinpointed as transverse myelitis.
Note: Why won't the company let the two who became seriously ill speak to the media? And why initially did they hide the fact that the illnesses were serious? And why are top vaccine executives now dumping their shares of stocks? For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and Big Pharma corruption from reliable major media sources.
On June 26, a small South San Francisco company called Vaxart made a surprise announcement: A coronavirus vaccine it was working on had been selected by the U.S. government to be part of Operation Warp Speed, the flagship federal initiative to quickly develop drugs to combat Covid-19. The race is on to develop a coronavirus vaccine, and some companies and investors are betting that the winners stand to earn vast profits from selling hundreds of millions – or even billions – of doses to a desperate public. Across the pharmaceutical and medical industries, senior executives and board members ... are making millions of dollars after announcing positive developments, including support from the government, in their efforts to fight Covid-19. After such announcements, insiders from at least 11 companies – most of them smaller firms whose fortunes often hinge on the success or failure of a single drug – have sold shares worth well over $1 billion since March. Senior officials appear to be pouncing on opportunities to cash out. And some companies have awarded stock options to executives shortly before market-moving announcements about their vaccine progress. Some companies are attracting government scrutiny for ... using their associations with Operation Warp Speed as marketing ploys. Vaxart's news release declared: "Vaxart's Covid-19 Vaccine Selected for the U.S. Government's Operation Warp Speed." But Vaxart is not among the companies selected to receive significant financial support from Warp Speed.
Note: MSN strangely removed this article a few days after posting it. A similar article by the New York Times titled "The race for a coronavirus vaccine is making some corporate insiders very rich" is available here. For more along these lines, see concise summaries of deeply revealing news articles on big Pharma corruption and the coronavirus from reliable major media sources.
One by one, vaccine developers at a White House roundtable convened by President Donald Trump in early March pitched their product as a viable solution to the coronavirus. StĂ©phane Bancel of Moderna Inc. glanced across the table at the nation's top infectious disease expert, Dr. Anthony Fauci, and said he is "very proud to be working with the US government and to have already sent, in only 42 days from the sequence of the virus, our vaccine to Dr. Fauci's team at the NIH." Bancel went on to say that he needed just "a few months" to start phase two of a three-part clinical trial of the sort that typifies vaccine development. (The entire process often takes more than a decade.) The day after the roundtable, the FDA green-lit Moderna's product for trial, making it the first vaccine candidate to advance to the first phase of a clinical study, in which an as-yet unapproved vaccine is injected into the arms of a small group of 45 human volunteers. The effort received another boost on April 16, when the federal Biomedical Advanced Research and Development Authority (BARDA) awarded Moderna up to $483 million to accelerate the development and manufacturing of the vaccine. The FDA allowed Moderna's RNA vaccine ... to essentially gloss over the animal-testing that typically precede clinical trials in humans. [Moderna's former director of chemistry Dr. Suhaib] Siddiqi said this is cause for alarm. "I would not let that [vaccine] be injected in my body," he said. "I would demand: Where is the toxicity data from the lab?"
Note: Read a New York Times/MSN article titled "Corporate Insiders Pocket $1 Billion in Rush for Coronavirus Vaccine." For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and vaccines from reliable major media sources.
Warren D. Ward, 48, was in high school when the swine flu threat of 1976 swept the U.S. A relative died in the 1918 flu pandemic, and the 1976 illness was feared to be a direct descendant of the deadly virus. “The government wanted everyone to get vaccinated,” Ward said. “But the epidemic never really broke out. It was a threat that never materialized.” The episode began in February 1976, when an Army recruit at Ft. Dix, N.J., fell ill and died from a swine flu virus thought to be similar to the 1918 strain. Several other soldiers at the base also became ill. The CDC ... called on President Ford and Congress to begin a mass inoculation. The $137-million program began in early October, but within days reports emerged that the vaccine appeared to increase the risk for Guillain-Barre syndrome, a rare neurological condition that causes temporary paralysis but can be fatal. More than 40 million Americans ... received the swine flu vaccine before the program was halted in December after 10 weeks. More than 500 people are thought to have developed Guillain-Barre syndrome after receiving the vaccine; 25 died. Only about 200 cases of swine flu and one death were ultimately reported. No one completely understands the causes of Guillain-Barre, but the condition can develop after a bout with infection or following surgery or vaccination. The federal government paid millions in damages. The pandemic, which some experts estimated at the time could infect 50 million to 60 million Americans, never unfolded.
Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
Louis Pasteur, one of the legendary figures in the history of science, lied about his research, stole ideas from a competitor and was deceitful in ways that would now be regarded as scientific misconduct if not fraud, according to a revisionist history published this month. "The Private Science of Louis Pasteur," by Dr. Gerald L. Geison of Princeton University, is based on an examination of Pasteur's 102 laboratory notebooks. Pasteur ... tried to reduce the virulence of microbes by exposing them to oxygen in order to make them suitable for vaccination. But in developing a vaccine against anthrax ... Pasteur adapted a method he had used a year earlier to produce a vaccine against chicken cholera. To head off competitors, Pasteur had purposely withheld reporting the simple method he used to prepare the chicken cholera vaccine. Pasteur impulsively accepted a public challenge to carry out the world's first public trial of any experimental vaccine. Pasteur's assistants injected his formula into 25 sheep, left another 25 unprotected and then injected all 50 with virulent anthrax bacteria. Only the vaccinated sheep survived. But, the notebooks show, Pasteur lied when he suggested publicly that his dramatically successful vaccine had been developed by exposing anthrax bacteria to oxygen. In fact he ... made his vaccine by secretly relying on a technique used by a rival, Jean-Joseph Toussaint. Eventually, Pasteur's oxygen method did produce an anthrax vaccine, but only after he had won a monopoly to produce the vaccine.
Note: For more on how scientific myths are perpetuated, see this fascinating article. For more along these lines, see concise summaries of deeply revealing news articles on corruption in science from reliable major media sources.
Moderna set off a frenzy on Wall Street earlier this month when it announced positive, preliminary results from its coronavirus vaccine trial. As the hype grew, the young biotech company and its leading investor wasted no time capitalizing on the briefly surging stock price. Even as critics accused Moderna of overhyping the results released on May 18, a series of transactions were executed before its share price fizzled over the next week. The timing of those deals, former SEC officials said, appear to be "highly problematic" and should be investigated for potential illegal market manipulation. Just hours after revealing the promising vaccine results, Moderna (MRNA) sold 17.6 million shares to the public. That share sale, unveiled after the closing bell on May 18, was priced at $76; Moderna traded at just $48 as recently as May 6. The deal instantly raised $1.3 billion. Two of Moderna's top executives also cashed in on the boom at their company, which had suddenly amassed a $29 billion market value despite the fact it has no marketed products. By the time the selling was disclosed to the public via securities filings, Moderna's stock price had crashed back to Earth. The timing of the transactions - coupled with concerns from some medical experts that Moderna overstated the significance of its Phase 1 vaccine trial - should be investigated by authorities. Thomas Gorman, [a] former SEC official, said the agency should "absolutely" be investigating the situation at Moderna.
Note: Why didn't the media report that the Moderna vaccine trial had a 20% serious injury rate in the high dose group? Learn about this and much more in this revealing article. For more along these lines, see concise summaries of deeply revealing news articles on Big Pharma corruption from reliable major media sources.
The chief scientist brought on to lead the Trump administration's vaccine efforts has spent the last several days trying to disentangle pieces of his stock portfolio and his intricate ties to big pharmaceutical interests. The scientist, Moncef Slaoui, is a venture capitalist and a former longtime executive at GlaxoSmithKline. Most recently, he sat on the board of Moderna, a Cambridge, Mass., biotechnology firm with a $30 billion valuation that is pursuing a coronavirus vaccine. He resigned when President Trump named him last Thursday to the new post as chief adviser for Operation Warp Speed, the federal drive for coronavirus vaccines and treatments. Just days into his job, the extent of Dr. Slaoui's financial interests in drug companies has begun to emerge: The value of his stock holdings in Moderna jumped nearly $2.4 million, to $12.4 million when the company released preliminary, partial data from an early phase of its candidate vaccine trial. Dr. Slaoui did not come on board as a government employee. Instead, he is on a contract ... that leaves him exempt from federal disclosure rules that would require him to list his outside positions, stock holdings and other potential conflicts. And the contract position is not subject to the same conflict-of-interest laws and regulations that executive branch employees must follow. Dr. Slaoui ... is not the first Trump administration official with close relationships to drug and health care companies. Alex M. Azar II, the health and human services secretary, is a former Eli Lilly executive.
Note: If the above link fails, this article is also available here. For more along these lines, see concise summaries of deeply revealing news articles on corruption in government and in Big Pharma from reliable major media sources.
It might not be until fall 2021 that Americans "can be completely safe" from COVID-19, Bill Gates said in a Tuesday interview with Judy Woodruff on PBS Newshour. That's because it will take more than a year before a vaccine can be developed and deployed, according to researchers working to develop a treatment for COVID-19. "The vaccine is critical, because, until you have that, things aren't really going to be normal," the billionaire philanthropist told Woodruff. "They can open up to some degree, but the risk of a rebound will be there until we have very broad vaccination." Social distancing is helping to lower the number of COVID-19 cases. The goal, Gates explained, is to get that number down to a point where "contact tracing" (a process in which those within close contact with an infected person are closely monitored) can be done, in order to maintain necessary quarantines. To understand what life in the U.S. will look like six to 12 months from now, Gates suggested China as a good model. "They are sending people back to work, but they're wearing masks. They're checking temperatures. They're not doing large sporting events. And so they have been able to avoid a large rebound," he said. Beyond that, "returning to some semblance of normal," as Woodruff put it, can be predicted by watching the behaviors of other countries. Sweden, for example, isn't "locking down quite as much," so their experience will be informative, Gates explained.
Note: In this video interview, Gates says we need to vaccinate everyone in the world. And he wants indemnity in case the vaccine he sponsors ends up killing or injuring many. Learn more about how Gates uses his billions to gain political power. And don't miss this most important video focused on how he is using fear of the virus to promote his agenda to require a "digital certificate" to ensure they've been vaccinated. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus pandemic from reliable major media sources.
Bill Gates ... just called for a complete and utter shutdown and quarantining of the entire American nation. “Despite urging from public health experts,” Gates wrote in a Washington Post opinion piece, “some states and counties haven’t shut down completely. This is a recipe for disaster. Because people can travel freely across state lines, so can the virus. The country’s leaders need to be clear: Shutdown anywhere means shutdown everywhere. Until the case numbers start to go down ... no one can continue business as usual or relax the shutdown.” He then added that the impacts of the new coronavirus could linger another 18 months or so, until a vaccine was developed. For the peons of America, work isn’t an option. It’s food. It’s survival. The fate of a hard-earned dream shouldn’t rest with a globalist billionaire who’s warning of dire coronavirus consequences to come — all the while making hands-over-fist coronavirus money. It’s a conflict of interest. WHO didn’t announce the coronavirus as a pandemic until the very day after Gates ... made a very large donation to a cause that benefits WHO. In a 2017 piece titled, “Meet the world’s most powerful doctor: Bill Gates,” Politico wrote: “Some billionaires are satisfied with buying themselves an island. Bill Gates got a United Nations health agency. Over the past decade, the world’s richest man has become the World Health Organization’s second-biggest donor, second only to the United States. … This largesse gives him outsized influence over its agenda. … The result, say his critics, is that Gates‘ priorities have become the WHO‘s.”
Very Important Note: To understand how the coronavirus is being used to exert more control over humanity, don't miss this incredibly important video focused on how Bill Gates is using fear around the coronavirus to push through his agenda to vaccinate everyone on the planet and then require a "digital certificate" to ensure they've been vaccinated. For other reliable, verifiable informing demonstrating how Gates' vaccine agenda has already harmed hundreds of thousands of children read this excellent article by Robert F. Kennedy, Jr.
A large scale malaria vaccine study led by the World Health Organization has been criticised by a leading bioethicist for committing a “serious breach” of international ethical standards. The cluster randomised study in Africa is already under way in Malawi, Ghana, and Kenya, where 720,000 children will receive the RTS,S vaccine, known as Mosquirix, over the next two years. Mosquirix, the world’s first licensed malaria vaccine, was positively reviewed by the European Medicines Agency, but its use is being limited to pilot implementation, in part to evaluate outstanding safety concerns that emerged from previous clinical trials. [Among these concerns] were a rate of meningitis in those receiving Mosquirix 10 times that of those who did not, increased cerebral malaria cases, and a doubling in the risk of death (from any cause) in girls. Charles Weijer, a bioethicist at Western University in Canada, told The BMJ that the failure to obtain informed consent from parents whose children are taking part in the study violates the Ottawa Statement, a consensus statement on the ethics of cluster randomised trials, of which Weijer is the lead author, and the Council for International Organizations of Medical Sciences’ International Ethical Guidelines. “The failure to require informed consent is a serious breach of international ethical standards,” he said.
Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
Two former Merck & Co Inc scientists accusing the drugmaker of falsifying tests of its exclusive mumps vaccine said in a court filing on Monday that Merck is refusing to respond to questions about the efficacy of the vaccine. Attorneys at Constantine Cannon, who represent the scientists, asked U.S. Magistrate Judge Lynne Sitarski of the Eastern District of Pennsylvania to compel Merck to respond to their discovery request, which asks the company to give the efficacy of the vaccine as a percentage. Instead of answering the question ... Merck has been consistently evasive, using “cut-and-paste” answers saying it cannot run a new clinical trial to determine the current efficacy, and providing only data from 50 years ago. The two scientists, Stephen Krahling and Joan Wlochowski, filed their whistleblower lawsuit in 2010 claiming Merck, the only company licensed by the Food and Drug Administration to sell a mumps vaccine in the United States, skewed tests of the vaccine by adding animal antibodies to blood samples. As a result, they said, Merck was able to produce test results showing that the vaccine was 95 percent effective, even though more accurate tests would have shown a lower success rate. The plaintiffs said these false results kept competitors from trying to produce their own mumps vaccines, since they were unable to match the effectiveness Merck claimed. The case is United States ex rel Krahling et al v. Merck & Co Inc, U.S. District Court, Eastern District of Pennsylvania, No. 10-4374.
Note: Why didn't this get reported widely? A search reveals no major media other than Reuters and WSJ covered this. This article in a local paper states the two whistleblowers were threatened by Merck with jail if they went public with this. It also says all students in a Syracuse University mumps outbreak had been properly vaccinated. This excellent article gives a 2019 update and reveals how the vaccines caused injury in a very high percentage of cases. For more, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
Just last month, the World Health Organization announced that two of three strains of polio had been eradicated. It's been one of the great success stories of modern medicine. The disease, which, of course, can lead to paralysis, has been reduced to just a handful of cases around the world. But now scientists say there's been a troubling setback. One of the vaccines used to prevent polio has actually been causing some people to get polio. The problem begins with what's called a live vaccine, which has little bits of weakened polio virus in it, given to children around the world. What seems to have gone wrong? The oral polio vaccine that's used primarily in low- and middle-income countries - it's been the workhorse of this global effort to eradicate polio. But it is a live vaccine. It's cheap. It's easy to administer. However, this live vaccine is continued to be used worldwide. And while you're doing that, some of that vaccine has gotten out into the world. And it's mutated. It starts circulating again, just like regular polio. But early on, it's just - it's still a vaccine. It's not dangerous. And then slowly, it sort of regains strength. And they're finding they can actually genetically see this - that scientists can actually trace it back directly to the vaccine. And now these vaccine-linked cases are actually causing more cases of paralysis each year than actual traditional - what scientists call wild polio. In the United States and in Europe ... we're using an injectable vaccine, which is a dead vaccine. It is not a live virus, and it cannot cause polio.
Note: For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
It's flu-shot season, and public health officials are urging everyone over 6 months of age to get one. For vaccine manufacturers, it's a bonanza: Influenza shots ... are a multibillion-dollar global business. But how good are they? Last month, in a step tantamount to heresy in the public health world, scientists at the Center for Infectious Disease Research and Policy at the University of Minnesota released a report saying that influenza vaccinations provide only modest protection for healthy young and middle-age adults, and little if any protection for those 65 and older. Moreover, the report's authors concluded, federal vaccination recommendations ... are based on inadequate evidence and poorly executed studies. Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy [stated,] "It does not protect as promoted. It's all a sales job: it's all public relations." While researching the report ... the authors discovered a recurring error in influenza vaccine studies that led to an exaggeration of the vaccine's effectiveness. They also discovered 30 inaccuracies in the statement on influenza vaccines put forth by the expert panel that develops vaccine recommendations, all of which favor the vaccine. The new report from the Center for Infectious Disease Research and Policy is not the first to point out the shortcomings of influenza vaccines, however. The Cochrane Collaboration, an international network of experts that evaluates medical research, concluded in a 2010 review that the vaccines ... have minimal impact in seasons when vaccines and viruses are mismatched.
Note: A 2020 study on the annual flu vaccine in the Annals of Internal Medicine concluded that "no evidence indicated that vaccination reduced hospitalizations or mortality among elderly persons." For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
The World Health Organization says Zambia has reported its first local case of polio since 1995, in a 2-year-old boy paralyzed by a virus derived from the vaccine. In a report this week, WHO said the case was detected on the border with Congo, which has reported 37 cases of polio traced to the vaccine this year. The U.N. health agency said there is no established link between the Zambia case and the ongoing Congo outbreak but said increased surveillance and vaccination efforts are needed, warning that “there is a potential for international spread.” In rare cases, the live virus in oral polio vaccine can mutate into a form capable of sparking new outbreaks. Nine African countries are currently battling polio epidemics linked to the vaccine as WHO and partners struggle to keep their efforts to eradicate polio on track. Elsewhere, cases have been reported in China, Myanmar and the Philippines. On Thursday, WHO and partners are expected to announce they have rid the world of type 3 polio virus. There are three types of polio viruses. Type 2 was eliminated years ago. That now leaves only type 1. But that refers only to polio viruses in the wild. Type 2 viruses continue to cause problems since they are still contained in the oral polio vaccine and occasionally evolve into new strains responsible for some vaccine-derived outbreaks. The global effort to eradicate polio was launched in 1988 and originally aimed to wipe out the potentially fatal disease by 2000.
Note: See an NPR article titled "Mutant Strains Of Polio Vaccine Now Cause More Paralysis Than Wild Polio." For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
Dena Churchill says that if the price for sharing her health "truths" is a $100,000 fine and losing her career, it's a price she's willing to accept. The former Halifax-based chiropractor surrendered her licence and admitted to charges of professional incompetence following a lengthy investigation by the Nova Scotia College of Chiropractors, all prompted by Churchill's persistent sharing of views on vaccines. CBC News began reporting on the complaints against Churchill in 2018, but she has declined to speak publicly until now. In a recent interview, Churchill said she believes there is a distinction between what she was posting on personal social media pages and what she was doing in her professional capacity. She said she felt "assaulted" that her professional governing body could mandate and govern her personal views. "I didn't want to take [the posts] down," she said. "This whole issue is not about what I was doing in my practice or what I was promoting in my practice ... I was reprimanded on my own personal views and wanting to share it with the people I love." Churchill said the information she was sharing was intended for just a few family members, although she also compared what she was doing to living in a building she discovered had arsenic in the water system. "I'd go knock on every door in that building to let them know because I would feel a human desire to help and to share information," she said.
Note: NBC also reports email service provider Mailchimp has removed several anti-vaccination activists from its platform and will no longer provide services to newsletters that push anti-vaccination content. Is this an assault on free speech? For more along these lines, see concise summaries of deeply revealing news articles on vaccines from reliable major media sources.
Important Note: Explore our full index to revealing excerpts of key major media news stories on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.